ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer
ICON (NASDAQ: ICLR), a leading healthcare intelligence and clinical research organization, has been recognized with multiple awards in the first half of 2024 for its leadership in clinical research, inclusion, sustainability, and as a top employer. At the CRO Leadership Awards 2024, ICON excelled in all categories, receiving individual accolades for data quality, project timelines, operational excellence, and technology. ICON's AI solution, Cassandra, was lauded at the Citeline 2024 awards for its innovative use of real-world data. The company was named Clinical Research Company of the Year at the PharmaTimes International Clinical Researcher of the Year awards, and its site network, Accellacare, won Best Clinical Trial Network at the Vaccine Industry Excellence Awards. HumanFirst, recently acquired by ICON, was named Best Clinical Trial Technology Solution Provider at the MedTech Breakthrough Awards 2024. ICON also received a Viddy Award for its digital services and was named Social & Equality Business of the Year at the PwC Business Post Sustainable Business Awards. Additionally, ICON was listed among Europe’s Climate Leaders in 2024 by the Financial Times and recognized as a top workplace in Ireland by LinkedIn.
- None.
- None.
At the CRO Leadership Awards 2024, ICON was recognised for its excellence in clinical research in all categories. The awards are based on direct feedback from sponsors that CROs have worked with over the last 18 months. ICON also received Individual Attribute Awards in the areas of data quality, meeting project timelines, operational excellence, technology for access to data, and therapeutic expertise.
ICON was also recognised for its technology solutions at the Citeline 2024 awards, which showcase excellence in clinical trial design and technological advancements. ICON’s AI solution, Cassandra, won for Excellence in Use of Real-World Data/Evidence. Citeline judges praised Cassandra as an “innovative and pragmatic system to help trial sponsors predict future post-marketing regulatory requirements and develop strategies to mitigate or eliminate those requirements early-on in their programs”.
The company was named Clinical Research Company of the Year at the PharmaTimes International Clinical Researcher of the Year awards. The awards are designed to challenge, recognise and reward the talent and passion of industry and academic researchers. Overall, ICON boasted over 50 employees who received gold, silver and bronze awards or who were nominated as finalists.
ICON’s site network, Accellacare, was named Best Clinical Trial Network at the 2024 Vaccine Industry Excellence Awards. These awards recognise outstanding efforts and positive contributions of organisations and individuals in the vaccine industry.
Recently acquired by ICON, HumanFirst, a company that enables better selection and integration of digital health technologies in clinical trials, was named Best Clinical Trial Technology Solution Provider at the 2024 MedTech Breakthrough Awards. These awards recognise the top companies, people, platforms and products in the health, fitness and medtech industries.
ICON's Creative & Digital Services and Global Medical Communications teams were winners of a 2024 Viddy Award. They received a Gold Award in the Non-Broadcast Short Form Web Videos category.
Acknowledging the progress the company has made through its ICON Cares program, the company was named the Social & Equality Business of the Year at the 2024 PwC Business Post Sustainable Business Awards. ICON was one of a record number of 150+ applicants to the awards, which are a benchmark for excellence in ESG-related business practices. Furthermore, ICON was included as one of Europe’s Climate Leaders in 2024, as compiled by the Financial Times in partnership with data provider Statista. The list comprises European companies that achieved the greatest reduction in their core emissions intensity between 2017 and 2022 and fulfilled further climate-related criteria including transparency of reporting, reduction of absolute emissions and further collaborations and commitments.
In recognition of its foundation and impact in
Steve Cutler, CEO, ICON commented: “These awards are a testament to the hard work, dedication and innovation of every employee at ICON. I am proud of our achievements, which reinforce our commitment to delivering value to our customers and our people and driving the future of clinical research.”
A full list of ICON’s industry awards can be viewed at www.iconplc.com/awards.
About ICON plc
ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in
ICON/ICLR-G
View source version on businesswire.com: https://www.businesswire.com/news/home/20240710959169/en/
Claire Quinn (GMT time zone)
Corporate Communications, ICON plc
claire.quinn@iconplc.com
+353 87 4066091
Weber Shandwick (PR adviser)
Lisa Henry (GMT time zone)
+447785 458203
lhenry@webershandwick.com
Source: ICON plc
FAQ
What awards did ICON (ICLR) receive in 2024?
Why was ICON's AI solution Cassandra recognized?
What did ICON achieve at the CRO Leadership Awards 2024?
How did ICON perform at the PharmaTimes International Clinical Researcher of the Year awards?
What is ICON's recognition in the inclusion and sustainability sector in 2024?
What accolade did ICON's site network, Accellacare, receive in 2024?
What recognition did HumanFirst, acquired by ICON, receive in 2024?
How was ICON recognized as an employer in 2024?
